Sentences with phrase «patient with lung cancer»

A prospective study showed that liquid biopsy is an effective and accurate clinical tool to identify presence of genetic mutations in patients with lung cancer.

«This research effort is important because it will assist in recommending effective, optimal treatments tailored specifically to older patients with lung cancer,» he said.

The booklet has been developed and reviewed by medical experts who treat patients with lung cancer.

Late detection and lack of effective therapies make the probability of survival of patients with lung cancer is very low.

Epidermal growth factor receptor, also called EGFR, is a biomarker found in certain patients with lung cancer.

Results of an initial study of tumors from patients with lung cancer or head and neck cancer suggest that the widespread acquired resistance to immunotherapy drugs known as checkpoint inhibitors may be due to the elimination of certain genetic mutations needed to enable the immune system to recognize and attack malignant cells.

The researchers found there was a decline in the relative proportion of patients with lung cancer meeting the USPSTF criteria overall, from 57 percent in 1984 - 1990 to 43 percent in 2005 - 2011.

The proportion of patients with lung cancer who smoked more than 30 pack - years declined, and the proportion of former smokers, especially those who quit smoking more than 15 years ago, increased.

Rhodes claims that in his research, the kit has had 85 percent accuracy in identifying patients with lung cancer.

Gromova, E. G., et al. «[Regulation of the indices of neuroendocrine status in surgical patients with lung cancer using optimal doses of ascorbic acid].»

In 2006, researchers at the Pine Street Foundation in Northern California reported that they had taught dogs to pinpoint patients with lung cancer (with 97 percent accuracy) and breast cancer (with 88 percent accuracy)- simply by sniffing their breath.

Salivary Biomarkers May Be Useful to Assess Stress State in Patients with Lung Cancer Undergoing Chemotherapy

Vascular endothelial growth factor receptor, also called VEGFR, is a biomarker found in certain patients with lung cancer.

Ping Yang M.D., Ph.D., of the Mayo Clinic, Rochester, Minn., and colleagues conducted a study to examine the trends in the proportion of patients with lung cancer meeting the USPSTF screening criteria.

April 4, 2016 Precision medicine brings new hope to those with advanced urothelial cancer Five of six patients with advanced metastatic urothelial cancer and at least one of two specific genetic abnormalities, responded to treatment with afatinib, which was approved in 2013 by the Food and Drug Administration for patients with lung cancer, researchers report online in the Journal of Clinical Oncology.

Research from McMaster University has identified new regulators of brain metastases in patients with lung cancer.

Patients with lung cancer are assumed to have earned it, having inhaled toxins for years.

You's team removed immune cells from a patient with lung cancer.

Researchers used molecular scissors called CRISPR / Cas9 to engineer immune cells that were then injected into a patient with lung cancer, Nature reports.

However, the Moffitt scientists suggest that it may be possible to target the TGF - β - miR183 - DAP12 pathway in patients with lung cancer to activate the immune system and kill cancer cells.

They also chose to study a type of K - Ras mutant called G12C (for Glycine - 12 to Cysteine), a K - Ras mutant prevalent in about seven percent of patients with lung cancer.

The results demonstrated that the patients with lung cancer had a higher breath temperature than those without.

In a test designed to show how the tool would be used in actual practice, Dr. Wang retrospectively tested iCAGES using detailed sequencing data from a patient with lung cancer.

An analysis of lung cancer incidence and screening found a decline in the proportion of patients with lung cancer meeting high - risk screening criteria, suggesting that an increasing number of patients with lung cancer would not have been candidates for screening, according to a study in the February 24 issue of JAMA.

«The decline in the proportion of patients meeting USPSTF high - risk criteria indicates that an increasing number of patients with lung cancer would not have been candidates for screening.

«For about 80 percent of our patients with lung cancer, we don't have tests like [the one for] ALK to tell us what treatments will work best,» Shaw says.

Novel strategies that are effective in treating brain metastases in patients with lung cancer are needed.

Now more than ever, IASLC needs to take leadership in optimizing the global management of patients with lung cancer and other thoracic malignancies.

Patients with lung cancer have better outcomes and higher cure rates when treated by a thoracic surgeon.

Further evidence that immunotherapy provides long - term survival benefit for patients with lung cancer was presented today at ELCC 2018 (European Lung Cancer Congress) in Geneva, Switzerland.

We did this review to find evidence that smoking cessation improves prognostic outcomes in patients with lung cancer, but in the absence of data from randomised controlled trials no causal inferences can be made.

Recent meetings of the European Society of Medical Oncology (October 7 - 11, 2016) and the IASLC Chicago Multidisciplinary Symposium in Thoracic Oncology (September 22 - 24, 2016) provided important updates and new information relevant to the multidisciplinary management of patients with lung cancer.

In patients with lung cancer, higher levels of HGF may indicate more aggressive disease.

A K - ras mutation called KRAS 1 is a biomarker found in certain patients with lung cancer.

Anaplastic lymphoma kinase, also called ALK, is a biomarker found in certain patients with lung cancer.

Lovly's clinical practice focuses primarily on the care of patients with lung cancer.

Those data are part of the Tracking Cancer Evolution through therapy (TRACERx) program, which recruited Swanton's patients with lung cancers.

Clinical trial showed Merck's immune boosting drug Keytruda is better than chemotherapy in patients with lung cancer.

A qualitative study of providing pro-active social support targeted to the carers of patients with lung cancer

After a diagnostic interview, 20 patients with lung cancer and intrusions are randomly allocated to one of the conditions.

MBSR (supplementary to care - as - usual) has been shown to be effective in reducing stress levels and improving quality of life in patients with lung cancer (Schellekens et al., 2017).

These findings are consistent with previous research, in which caregiving burden among spouses of patients with lung cancer was related to 3 - and 6 - month follow - up distress in spouses.